The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Laxmikant Mujumdar
Goldline Pharmaceutical Ltd. Press Release Sep 01 2026
Earlier from Goldline Pharmaceutical
- Goldline Pharmaceutical Ltd. Press Release Aug 31 2026
- Goldline Pharmaceutical Ltd. Press Release Aug 29 2026
- Goldline Pharmaceutical Ltd. Press Release Aug 07 2026
- Goldline Pharmaceutical Ltd. Press Release Jul 30 2026